2011
DOI: 10.2147/jpr.s16610
|View full text |Cite
|
Sign up to set email alerts
|

Somatotopy of placebo analgesia is independent of spatial attention

Abstract: Placebo analgesia is being increasingly appraised as an effective support of pharmacological and surgical treatments of pain. The understanding of its neurobiological and psychological basis is therefore of high clinical relevance. It has been shown that placebo analgesia is somatotopically organized and relies on endogenous opioids. However, it is not clear whether temporal fluctuations of cue-dependent spatial attention account for the site specificity of placebo analgesia or whether a somatotopic placebo ef… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 22 publications
(35 reference statements)
1
0
0
Order By: Relevance
“…These findings are reminiscent of studies in the field of placebo analgesia, where pain reduction was observed only in the placebo-treated part of the body (Montgomery and Kirsch, 1996; Benedetti et al, 1999; Domnick et al, 2011) and could be reversed by the opioid-antagonist naloxone, suggesting a somatotopic activation of endogeneous opioid systems (Benedetti et al, 1999). Placebo effects on inner organ functions may likewise be mediated by organotopic activation of visceromotor representations in the insular and medial prefrontal cortices (Meissner, 2000, 2009, 2011; Meissner and Ziep, 2011).…”
Section: The Placebo Effect and The Autonomic Nervous System: An Invesupporting
confidence: 56%
“…These findings are reminiscent of studies in the field of placebo analgesia, where pain reduction was observed only in the placebo-treated part of the body (Montgomery and Kirsch, 1996; Benedetti et al, 1999; Domnick et al, 2011) and could be reversed by the opioid-antagonist naloxone, suggesting a somatotopic activation of endogeneous opioid systems (Benedetti et al, 1999). Placebo effects on inner organ functions may likewise be mediated by organotopic activation of visceromotor representations in the insular and medial prefrontal cortices (Meissner, 2000, 2009, 2011; Meissner and Ziep, 2011).…”
Section: The Placebo Effect and The Autonomic Nervous System: An Invesupporting
confidence: 56%